Riskpilot← Back to searchSign inGet full accessKONNERUD APOTEK AS
ASActiveOrg 927185245Bernåsbakken 2, 3032 DrammenRetail sale of pharmaceutical products · NACE 4773Est. 20218 employees
Revenue 2024
NOK 12,4M
-1% vs 2023
EBITDA margin
2.1%
+9% vs 2023
Equity ratio
-22.3%
Financial strength
Net profit 2024
NOK -39K
+63% vs 2023
| Revenue | NOK 12,4M | -1% |
| EBITDA | NOK 258K | +9% |
| Net profit | NOK -39K | +63% |
| Total assets | NOK 2,8M | -38% |
| Equity | NOK -631K | -6% |
| Employees | 8 | — |
Legal name
KONNERUD APOTEK AS
Org number
927185245
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
3. juni 2021
Share capital
NOK 30 000
Employees
8 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Eie og drive apotek, herunder konsulenttjenester innenfor apotekerbransjen og lege- og helserelaterte produkter, samt øvrig virksomhet i tilknytning til dette.
Address
Bernåsbakken 2, 3032 Drammen
Phone
+4731900730
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 2 391 | 11 278 | 12 511 | 12 407 |
| Staff expenses | −416 | −1 970 | −1 935 | −1 750 |
| EBITDA | −286 | 203 | 236 | 258 |
| Depreciation & amort. | −72 | −233 | −233 | −229 |
| EBIT | −358 | −30 | 3 | 28 |
| Net financials | −35 | −89 | −108 | −67 |
| Profit before tax | −392 | −119 | −105 | −39 |
| Tax | −0 | −0 | −0 | −0 |
| Net profit | −392 | −119 | −105 | −39 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 4 216 | 3 312 | 4 571 | 2 836 |
| Equity | −368 | −487 | −593 | −631 |
| Long-term debt | 1 693 | 1 436 | 1 179 | 0 |
| Short-term debt | 2 891 | 2 364 | 3 985 | 3 467 |
| Total debt | 4 584 | 3 800 | 5 164 | 3 467 |
EBITDA margin
2.1%
This company
15.8%
Market median
-87% vs market
20212024
Equity ratio
-22.3%
This company
38.2%
Market median
-158% vs market
20212024
Return on equity
-3850900.0%
This company
18.4%
Market median
-20928904% vs market
20212024
Net profit margin
-0.3%
This company
8.1%
Market median
-104% vs market
20212024
Asset turnover
4.38×
This company
1.12×
Market median
+291% vs market
20212024
Debt / equity
5.49×
This company
0.62×
Market median
-785% vs market
20212024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-04-15 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SA Chief Executive Officer | Chief Executive Officer | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2025 | |
| Chairman | 2025 | |
| Former (1) | ||
| Chairman | 2021 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Ansatt I Mjøndalen Apotek As
KONNERUD APOTEK AS Board members of KONNERUD APOTEK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Syed Abad-Ul-Hassan | Chief Executive Officer | 0 companies |
| Aisha Azeem | Board of Directors | 0 companies |
| Katarzyna Czulinska | Chairman | 0 companies |
| Zaheer Ali | Chairman | 0 companies |